Aspen Aerogels (NYSE:ASPN) Shares Gap Up – What’s Next?

Aspen Aerogels, Inc. (NYSE:ASPN) shares gapped up before the market opened on Thursday . The stock had previously closed at $16.86, but opened at $18.78. Aspen Aerogels shares last traded at $17.68, with a volume of 1,682,907 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Piper Sandler cut their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Barclays initiated coverage on shares of Aspen Aerogels in a report on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price target on the stock. Roth Mkm reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. Finally, TD Cowen raised their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. One research analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels has a consensus rating of “Moderate Buy” and an average target price of $29.40.

Aspen Aerogels Stock Down 1.8 %

The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The stock has a market capitalization of $1.28 billion, a P/E ratio of -1,685.00 and a beta of 2.21. The stock has a fifty day moving average price of $23.58 and a 200 day moving average price of $24.66.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The firm had revenue of $117.80 million during the quarter, compared to analyst estimates of $101.99 million. During the same period in the previous year, the business earned ($0.22) EPS. The business’s revenue for the quarter was up 144.4% on a year-over-year basis. On average, research analysts forecast that Aspen Aerogels, Inc. will post 0.1 earnings per share for the current year.

Insider Activity at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by insiders.

Institutional Trading of Aspen Aerogels

Institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Aspen Aerogels by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock valued at $341,000 after purchasing an additional 1,339 shares during the period. nVerses Capital LLC raised its stake in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock worth $161,000 after buying an additional 1,800 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Aspen Aerogels by 15.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after buying an additional 1,938 shares during the period. Point72 Hong Kong Ltd purchased a new stake in Aspen Aerogels in the second quarter worth about $84,000. Finally, Quent Capital LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at approximately $118,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.